COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1732: Articles 17311-17320  | Next

Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
Peng, J., Mann, S. A., Mitchell, A. M., Liu, J., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., Li, L. M., McGeever, A., Chow, E. D., IDseq Team, , Marquez, C., Nakamura, R., Rubio, L., Chamie, G., Jones, D., Jacobo, J., Rojas, S., Tulier-Laiwa, V., Black, D., Martinez, J., Naso, J., Schwab, J., Petersen, M., Havlir, D., DeRisi, J. L.
10.1101/2021.03.01.21252705 — Posted: 2021-03-03
Atorvastatin effectively inhibits late replicative cycle steps of SARS-CoV-2 in vitro
Zapata-Cardona, M. I., Florez-Alvarez, L., Zapata-Builes, W., Guerra-Sandoval, A., Guerra-Almonacid, C., Hincapie-Garcia, J., Rugeles, M. T., Hernandez, J. C.
10.1101/2021.03.01.433498 — Posted: 2021-03-03
An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis
Cushnan, D., Bennett, O., Berka, R., Bertolli, O., Chopra, A., Dorgham, S., Favaro, A., Ganepola, T., Halling-Brown, M., Imreh, G., Jacob, J., Jefferson, E., Lemarchand, F., Schofield, D., Wyatt, J. C., NCCID Collaborative
10.1101/2021.03.02.21252444 — Posted: 2021-03-03
Experiences of COVID-19 Recovered Patients - A Qualitative Case Study from a Hotspot in Saudi Arabia
Alhajjaji, A., Kurdi, A., Faqeh, S., Alansari, S., Abdulaziz, A., Allihyani, M., Almaghamsi, O., Cheema, E., Ali, M.
10.1101/2021.03.01.21252508 — Posted: 2021-03-03
365 days with COVID-19 in Iran: data analysis and epidemic curves
Sahafizadeh, E., Talatian Azad, S.
10.1101/2021.03.02.21252694 — Posted: 2021-03-03
Towards Understanding the COVID-19 Case Fatality Rate
Yan, D., Chen, A., Yang, B.
10.1101/2021.03.01.21252698 — Posted: 2021-03-03
On the Environmental Determinants of COVID-19 Seasonality
Choi, Y.-W., Tuel, A., Eltahir, E. A. B.
10.1101/2021.03.01.21252243 — Posted: 2021-03-03
Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients
Antar, A. A. R., Yu, T., Pisnic, N., Azamfirei, R., Tornheim, J. A., Brown, D. M., Kruczynski, K., Hardick, J. P., Sewell, T., Jang, M., Church, T., Walch, S. N., Reuland, C., Bachu, V. S., Littlefield, K., Park, H.-S., Ursin, R. L., Ganesan, A., Kusemiju, O., Barnaba, B., Charles, C., Prizzi, M., Johnstone, J. R., Payton, C., Dai, W., Fuchs, J., Massaccesi, G., Armstrong, D. T., Townsend, J. L., Keller, S. C., Demko, Z. O., Hu, C., Wang, M.-C., Sauer, L. M., Mostafa, H. H., Keruly, J. C., Mehta, S. H., Klein, S. L., Cox, A. L., Pekosz, A., Heaney, C. D., Thomas, D. L., Blair, P. W., Manabe, Y. C.
10.1101/2021.03.02.21252420 — Posted: 2021-03-03
A single dose of SARS CoV 2 FINLAY FR 1A dimeric RBD recombinant vaccine enhances neutralization response in COVID19 convalescents, with excellent safety profile. A preliminary report of an open-label phase 1 clinical trial
Chang-Monteagudo, A., Ochoa-Azze, R., Climent-Ruiz, Y., Macias-Abraham, C., Rodriguez-Noda, L., Valenzuela-Silva, C., Sanchez-Ramirez, B., Perez-Nicado, R., Gonzalez-Mugica, R., Hernandez-Garcia, T., Orosa-Vazquez, I., Diaz-Hernandez, M., Garcia-Garcia, M. d. l. A., Jerez-Barcelo, Y., Triana-Marrero, Y., Ruiz-Villegas, L., Rodriguez-Prieto, L., Puga-Gomez, R., Guerra-Chaviano, P. P., Zuniga-Rosales, Y., Marcheco-Teruel, B., Rodriguez-Acosta, M., Noa-Romero, E., Enriquez-Puertas, J., Porto-Gonzalez, D., Leon-Monzon, K., Chen, G.-W., Herrera Martinez, L., Valdes-Balbin, Y., Garcia-Rivera, D., Verez-Bencomo, V.
10.1101/2021.02.22.21252091 — Posted: 2021-03-03
Genetic variation of IFNL4 is associated with COVID-19
Saponi-Cortes, J. M. R., Rivas, M. D., Sanchez Munoz-Torrero, J. F., Zamorano, J.
10.1101/2021.03.01.21252696 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).